IRB Policies Archive

1. Principles and Authority
1.1 - Principles Governing the Committee
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF
1.2 - Authority of the Committee
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF
1.3 - Federalwide Assurances
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF - refer to OHRP Web site for current FWA terms
1.4 - Studies Requiring Review
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/25/2005 - PDF
        3/5/2008 - PDF
1.5 - IRB Independence from Undue Influence
        2/8/2005 - PDF
1.6 - Access to General Counsel
        2/8/2005 - PDF
1.7 - Executive Committee
        1/24/2011 - PDF
        2/8/2005 - PDF

2. Relationships
2.1 - To the Administration
        11/18/2002 - HTML
        8/23/2004 - PDF
2.2 - To Other University or Affiliated Committees/Departments
        11/18/2002 - HTML
        1/29/2005 - PDF
        2/8/2005 - PDF
2.3 - To Other Institutions
        11/18/2002 - HTML
        3/5/2004 - PDF
2.4 - To the UAMS Office of Research Compliance
        11/18/2002 - HTML
        3/5/2004 - PDF
        3/5/2004 - PDF
2.5 - To the Office of Research and Sponsored Programs
        11/18/2002 - HTML
        3/5/2004 - PDF
2.6 - To Regulatory Agencies
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF
        4/5/2007 - PDF
        2/8/2005 - PDF
2.7 - Engagement
        7/23/2004 - PDF - the UAMS IRB follows the most current OHRP Guidance on
        Engagement as per the HRPP Plan
2.8 - International Research
        7/23/2004 - PDF
        7/23/2004 - PDF

3. Committee Membership
3.1 - Qualifications of Committees
        11/18/2002 - HTML
        3/5/2004 - PDF
        6/1/2005 - PDF
3.2 - Quorum
        11/18/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
3.3 - Conflict of Interest
        10/10/2002 - HTML
        3/5/2004 - PDF
        2/8/2005 - PDF
3.4 - Chairpersons
        11/18/2002 - HTML
        3/5/2004 - PDF
        3/29/2007 - PDF
3.5 - Vice-Chairpersons
        11/18/2002 - HTML
        3/12/2004 - PDF
        3/12/2004 - PDF
3.6 - Members
        11/18/2002 - HTML
        3/12/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
3.7 - Alternate Members
        11/18/2002 - HTML
        3/12/2004 - PDF
        3/12/2004 - PDF
3.8 - IRB Reviewer Training Requirements
        11/18/2002 - HTML
        3/12/2004 - PDF
        2/8/2005 - PDF
        3/29/2007 - PDF
3.9 - Consultants
        11/18/2002 - HTML
        3/12/2004 - PDF
        2/8/2005 - PDF

4. Committee Operations
4.1 - Number of Committees
        11/18/2002 - HTML
        3/12/2004 - PDF
        2/8/2005 - PDF
4.2 - Sub-committees
        11/18/2002 - HTML
        3/12/2004 - PDF
4.3 - Meeting Schedule
        11/18/2002 - HTML
        3/12/2004 - PDF
4.4 - Assignment of Primary Reviewers
        11/18/2002 - HTML
        8/25/2004 - PDF
        2/8/2005 - PDF
4.5 - Functions of the IRB Committee
        11/18/2002 - HTML
        8/25/2004 - PDF - addressed in other IRB policies
4.6 - Duties of IRB Manager or His/Her Designee
        11/18/2002 - HTML
        3/12/2004 - PDF
4.7 - Participant Phone Calls
        2/8/2005 - PDF
4.8 - IRB Staff Member Training
        2/8/2005 - PDF - Administrative Guide Policy 16.1.06 outlines the educational
        requirements for IRB Staff

return to top

5. Records
5.1 - IRB Records
        11/18/2002 - HTML
        8/25/2004 - PDF
        2/8/2005 - PDF
5.2 - Database
        11/18/2002 - HTML
        4/9/2004 - PDF
5.3 - Protocols Reviewed
        11/18/2002 - HTML
        4/9/2004 - PDF
        2/8/2005 - PDF
        9/22/2005 - PDF - addressed in IRB Policy 5.1

6. Documentation
6.1 - Agenda
        2/6/2003 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
6.2 - Written Procedures Governing the Committee
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF - addressed in other IRB policies
6.3 - Meeting Minutes
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
6.4 - Membership Roster
        7/31/2002 - HTML
        5/7/2004 - PDF

7. Procedures for Study Review
7.1 - Criteria for IRB Approval of Research
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
7.2 - Investigator and Sub-Investigator Qualifications
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
7.3 - Studies Exempt from Review
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
7.4 - Standard or Full Committee Review
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
        3/5/2008 - PDF
7.5 - Expedited Review
        7/31/2002 - HTML
        5/7/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
        3/13/2008 - PDF
        7/28/2008 - PDF
7.6 - Continuing Review
        10/11/2002 - HTML
        5/13/2004 - PDF
        2/8/2005 - PDF
        3/5/2008 - PDF
        7/28/2008 - PDF
7.7 - Progress and Final Reports
        7/31/2002 - HTML
7.8 - Data and Safety Monitoring Plan
        7/31/2002 - HTML
        8/18/2004 - PDF
        2/8/2005 - PDF
7.9 - Suspension or Termination of Approval for Cause
        7/31/2002 - HTML
        5/20/2004 - PDF
        2/8/2005 - PDF

8. Change in Protocol
8.1 - Changing Study Protocol
        11/9/2002 - HTML
        5/20/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
        3/5/2008 - PDF
8.2 - Change in Principal Investigator
        7/31/2002 - HTML
        5/20/2004 - PDF
8.3 - Off-Campus Duty Assignment (Sabbatical) or Leave of Absence
        7/31/2002 - HTML
        5/20/2004 - PDF

9. IRB Decisions
9.1 - Range of IRB Decisions
        7/31/2002 - HTML
        8/26/2004 - PDF
        2/8/2005 - PDF
        6/1/2005 - PDF
        4/5/2007 - PDF
        3/5/2008 - PDF
        7/28/2008 - PDF
9.2 - IRB Notification of Meeting Decisions
        7/31/2002 - HTML
        8/26/2004 - PDF)

10. Principal Investigator Responsibilties
10.1 - Principal Investigator Training
          10/10/2002 - HTML
          6/10/2004 - PDF
          6/1/2005 - PDF - Administrative Guide Policy 16.1.06 outlines the educational
          requirements for Research Personnel
10.2 - Unanticipated Problems Involving Risks to Participants or Others and Imminent
          Threat of Adverse Event -- Investigator Reporting Requirements and IRB Actions
          10/10/2002 - HTML
          7/7/2004 - PDF
          2/8/2005 - PDF
          6/1/2005 - PDF
          3/5/2008 - PDF
          7/28/2008 - PDF
10.3 - Principal Investigator IRB General IRB Reporting Requirements
          3/11/2005 - PDF

11. Appeals and Reconsiderations
11.1 - Appeals and Reconsiderations
          7/31/2002 - HTML
          6/10/2004 - PDF

return to top

12. Quality Assurances
12.1 - Educational Activities for IRB Reviewers
          7/31/2002 - HTML
          6/10/2004 - PDF - Administrative Guide Policy 16.1.06 and IRB Policy 3.8 outline
          the educational requirements for IRB Reviewers
12.2 - IRB Monitoring or Audits
          7/31/2002 - HTML
          6/10/2004 - PDF
          2/8/2005 - PDF
          6/1/2005 - PDF - addressed in other IRB policies
12.3 - Food and Drug Administration Monitoring or Reviews of the IRB -- Information
          for the Reviewer and Investigator
          7/31/2002 - HTML
          6/10/2004 - PDF - refer to current FDA guidance
12.4 - Non-compliance with Human Research Protection Program Requirements
          2/8/2005 - PDF
          6/1/2005 - PDF
          4/5/2007 - PDF
          10/5/2007 - PDF
          3/5/2008 - PDF - addressed in IRB Policy 12.5
12.5 - Reports of Potential Non-compliance
          3/5/2008 - PDF
12.6 - Findings of Non-compliance Under IRB Policy 12.5
          3/5/2008 - PDF

13. Confidentiality
13.1 - Certificates of Confidentiality
          10/10/2002 - HTML
          6/10/2004 - PDF
          6/10/2004 - PDF
13.2 - Confidentiality in Archived Data -- Social Science
          10/10/2002 - HTML
          6/10/2004 - PDF
13.3 - HIPAA Privacy Rule
          6/10/2004 - PDF - addressed in Administrative Guide Policy 3.1.27
13.4 - Criteria for the Release of an FDA 483
          9/10/2004 - PDF - contact the Office of Research Compliance for issues related to
          the release of an FDA 483

14. Recruitment Practices
14.1 - Selection of Subjects
          10/10/2002 - HTML
          6/24/2004 - PDF
14.2 - Subject Compensation
          10/10/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
14.3 - Advertising for Study Subjects
          10/10/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
14.4 - Compensation to Investigators and Health Care Workers for Enrolling Subjects
          10/10/2002 - HTML
          6/24/2004 - PDF
          6/24/2004 - PDF

15. Consent
15.1 - Elements of Informed Consent Documents and Process
          10/11/2002 - HTML
          8/25/2004 - PDF
          2/8/2005 - PDF
          6/1/2005 - PDF
          9/22/2005 - PDF
          4/5/2007 - PDF
          5/13/2008 - PDF
          7/28/2008 - PDF
          1/29/2010 - PDF
          2/1/2010 - PDF
          6/3/2010 - PDF
15.2 - Consent Exceptions: Emergency Use of a Test Article
          10/11/2002 - HTML
          8/24/2004 - PDF
15.3 - Waivers of Signed Informed Consent Documents and Waivers of Informed
          Consent Elements
          10/11/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
          6/1/2005 - PDF
          3/13/2008 - PDF
15.4 - Non-English-Speaking Research Subjects
          8/25/2004 - PDF
          7/28/2008 - PDF
15.5 - Documentation of Informed Consent
          4/5/2007 - PDF
          3/5/2008 - PDF

16. Risk/Benefit Analysis: Guidance for Reviewers
16.1 - Risk/Benefit Analysis
          7/31/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF

17. Special Populations
17.1 - Children in Research
          10/10/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
          6/11/2008 - PDF
17.2 - Cognitively Impaired Persons
          10/10/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
17.3 - Economically and Educationally Disadvantaged
          10/10/2002 - HTML
          8/26/2004 - PDF - addressed in other IRB policies
17.4 - Institutionalized Persons/Subjects in Long Term Care
          10/10/2002 - HTML
          6/24/2004 - PDF
          2/8/2005 - PDF
17.5 - International Research
          7/31/2002 - HTML
          8/24/2004 - PDF -- addressed in IRB Policy 2.8
17.6 - Minorities
          10/10/2002 - HTML
          8/24/2004 - PDF
17.7 - Non-English Speaking
          11/18/2002 - HTML
17.8 - Pregnant Women, Fetus, and Human In Vitro Fertilization
          11/18/2002 - HTML
          7/9/2004 - PDF
          2/8/2005 - PDF
17.9 - Prisoners in Research
          11/18/2002 - HTML
          8/24/2004 - PDF
          2/8/2005 - PDF
17.10 - Students, Employees and Healthy Volunteers
            10/10/2002 - HTML
            8/25/2004 - PDF
17.11 - Stored Data or Tissues
            7/31/2002 - HTML
            8/25/2004 - PDF
17.12 - Terminally Ill Patients
            11/18/2002 - HTML
            4/15/2004 - PDF
17.13 - Traumatized and Comatose Patients (the archived version of 17.13 differs in
            subject from 2/25/2005 policy no. 17.13 [Legally Authorized Representatives])
            11/18/2002 - HTML
            2/25/2005 - PDF

18. Drugs and Devices
18.1 - Drug Trials
          7/31/2002 - HTML
          4/15/2004 - PDF
          2/8/2005 - PDF
18.2 - Investigational Devices
          7/31/2002 - HTML
          4/15/2004 - PDF
          2/8/2005 - PDF
18.3 - Emergency Use of a Test Article or Drug or Biologic (Source: FDA Information
          Sheets Guidance for Institutional Review Boards and Clinical Investigators 1998
          Update)
          7/31/2002 - HTML
          8/26/2004 - PDF
          2/8/2005 - PDF
          3/5/2008 - PDF
18.4 - Emergency Use of an Unapproved Medical Device (Source: FDA Information
          Sheets Guidance for Institutional Review Boards and Clinical Investigators 1998
          Update)
          7/31/2002 - HTML
          8/26/2004 - PDF
          2/8/2005 - PDF
          3/5/2008 - PDF - addressed in IRB Policy 18.3
18.5 - Emergency Use of an Investigational Drug (IND) or Biologic
          7/31/2002 - HTML

19. Human Genetics Guidance
19.1 - Human Genetics
          7/31/2002 - HTML
          1/30/2004 - PDF

20. Questions, Concerns, Suggestions and Complaints
20.1 - Questions, Concerns, Suggestions and Complaints
9/1/2007 - PDF

Full Version of Retired IRB Standard Operating Policies (all policies in this full version designated by the last revision date)

return to top

return to current IRB standard operating policies and procedures

Back to IRB Home